Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.50
Delayed Data
As of Apr 01
 +0.05 / +2.04%
Today’s Change
1.00
Today|||52-Week Range
8.46
-1.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues2.0M2.0M854.0K896.0K
 
 
 
 
 
Depreciation And Amortization5.0K6.0K7.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses11.0M13.6M14.2M12.1M
 
 
 
 
 
Research And Development7.6M7.2M6.9M6.0M
 
 
 
 
 
Total Operating Expenses11.0M13.6M14.2M12.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.0M-11.6M-13.3M-11.2M
 
 
 
 
 
Extraordinary Credit0.00333.0K0.00--
 
 
Extraordinary Charge0.000.00-1.6M--
 
 
Interest Expense On Debt547.0K470.0K391.0K311.0K
 
 
 
 
 
Other Expenses-5.1M-40.0K11.0K10.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M-11.8M-15.3M-1.3M
 
 
 
 
 
Net Income-14.6M-11.8M-15.3M-1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.3M60.2M60.5M63.0M
 
 
 
 
 
Shares To Calculate EPS Diluted56.3M61.9M60.5M63.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.20-$0.25-$0.02
 
 
 
 
 
EPS Diluted-$0.26-$0.20-$0.25-$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account